Alzheimers brain protein may provide target for treating mental retardation

Monday, June 14th, 2010

From the perspective of neuroscientists, Alzheimer’s disease and Down syndrome have at least one thing in common: patients with both diseases have an accumulation of ²-amyloid protein in their brains. Scientists now provide evidence that drugs which help reduce the level of ²-amyloid in the brains of Alzheimer’s patients may ... continue reading